Nitrotyrosine Monoclonal Antibody Market Overview

Ajouter une nouvelle offre d'emploi Health

2026-06-18 09:49:25 -

The Nitrotyrosine Monoclonal Antibody Market is poised for substantial growth, valued at USD 500 million in 2024 and projected to reach USD 1,500 million by 2035 at a CAGR of 10.6%. Nitrotyrosine serves as a critical biomarker for oxidative stress and nitrosative damage, making these monoclonal antibodies essential tools in both research and clinical diagnostics. The market encompasses IgG,...

0 Commentaires 0 Parts 6 Vue 0 Aperçu